95,075 total recalls in our database
Keyera Energy Inc., of Houston, Texas
The recalled propane gas does not contain sufficient levels of odorant to help alert consumers to a gas leak. Failure to detect leaking gas can present fire, explosion and thermal burn hazards.
Grand Canyon Foods International
An FDA inspection revealed products that contained Yellow 5 and soy lecithin failed to declare the presence of Yellow 5 and soy.
Raley's Family of Fine Stores
It was discovered that peanuts were not listed in the Contains Statement on Raley's Peanut Butter Brownies; peanuts are listed in the statement of identity and correctly listed as an ingredient.
Flowers Bakery Of Montgomery
Undeclared allergens: Product was mislabeled due to undeclared Milk and Soy
Flowers Bakery Of Montgomery
Undeclared allergens: Product was mislabeled due to undeclared Milk and Soy
Nature's Only Choice
The Vitamin B17 containing product is considered to be a prescription drug, new drug, and unapproved new drug.
Morgan Foods, Inc. is voluntarily recalling Great Value Brand Gluten Free Tomato Soup due to undeclared allergen milk.
Grand Canyon Foods International
An FDA inspection revealed products that contained Yellow 5 and soy lecithin failed to declare the presence of Yellow 5 and soy.
Firm was notified by manufacturer in Italy that Pistachio Gelato contained the color sodium copper chlorophyllins (SCC), which is not authorized by FDA as a color additive for this product type.
Shawnee Milling Company
Product may contain metal fragments.
Michael's Bakery Products
The product contains pecans which are not declared on the product labeling.
CGMP Deviations: Products manufactured with an ingredient that exceed the benzene levels allowed in drug products.
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contamination
Milbar Laboratories
Subpotent
Teva Pharmaceuticals USA
Failed Stability Specifications
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared tadalafil. The presence of tadalafil makes Rhino Extreme 50000 an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.
Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release.
Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release.
Mylan Pharmaceuticals
CGMP Deviations
Mylan Pharmaceuticals
CGMP Deviations